nicotinell classic 4 mg medicinsk tyggegummi
glaxosmithkline consumer healthcare aps - nicotin - medicinsk tyggegummi - 4 mg
tavegyl 1 mg/ml injektionsvæske, opløsning
glaxosmithkline consumer healthcare aps - clemastin - injektionsvæske, opløsning - 1 mg/ml
tavegyl 1 mg tabletter
glaxosmithkline consumer healthcare aps - clemastinfumarat - tabletter - 1 mg
prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals
glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. denne angivelse er baseret på immunogenicitet data fra raske forsøgspersoner i alderen fra 18 år og op efter administration af to doser vaccine, der er fremstillet af en/vietnam/1194/2004 nibrg-14 (h5n1) (se afsnit 5. prepandemic influenza vaccine (h5n1) (split virion, inaktiveret, adjuvanted) glaxosmithkline biologicals 3. 75 µg bør anvendes i overensstemmelse med officielle retningslinjer.
voltaren dolo 12,5 mg filmovertrukne tabletter
glaxosmithkline consumer - diclofenackalium - filmovertrukne tabletter - 12,5 mg
voltaren dolo 12,5 mg kapsler, bløde
glaxosmithkline consumer - diclofenackalium - kapsler, bløde - 12,5 mg
voltaren dolo 25 mg overtrukne tabletter
glaxosmithkline consumer - diclofenackalium - overtrukne tabletter - 25 mg
celsentri
viiv healthcare b.v. - maraviroc - hiv infektioner - antivirale midler til systemisk anvendelse - celsentri, in combination with other antiretroviral medicinal products, is indicated for treatment experienced adults, adolescents and children of 2 years of age and older and weighing at least 10 kg infected with only ccr5-tropic hiv-1 detectable,.
tivicay
viiv healthcare bv - dolutegravir - hiv infektioner - antivirale midler til systemisk anvendelse - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.
dovato
viiv healthcare b.v. - dolutegravir natrium, lamivudin - hiv infektioner - antivirale midler til systemisk anvendelse - dovato er indiceret til behandling af human immundefekt virus type 1 (hiv-1) infektion hos voksne og unge over 12 år, som vejer mindst 40 kg, og som er uden kendt eller formodet resistens over for integrase inhibitor klasse, eller lamivudin.